Figure 6
Figure 6. TKO-BLT mice mount specific humoral and cellular immune responses to HIV infection. (A) Plasma collected at 8 wpi from 6 intraperitoneally infected mice injected with 3000, 7000, or 20 000 TCIU of HIVJR-CSF or 2 uninfected vehicle control injected mice was assayed by ELISA for combined IgM, IgA, or IgG antibodies or only IgG antibodies specific for HIVJR-CSF gp120 protein. Each line represents data from a single mouse. (B) At 7 wpi, 3 pooled spleens from HIV+ mice and 3 control HIV− spleens were depleted of murine leukocytes prior to ELISpot assay to determine specific cellular responses to pools of 8 overlapping HIV peptides that covered the HIVJR-CSF proteome. Positive responses (denoted by an asterisk) had >50 spots/106 splenocytes and were twofold over vehicle-only (dimethylsulfoxide) controls.

TKO-BLT mice mount specific humoral and cellular immune responses to HIV infection. (A) Plasma collected at 8 wpi from 6 intraperitoneally infected mice injected with 3000, 7000, or 20 000 TCIU of HIVJR-CSF or 2 uninfected vehicle control injected mice was assayed by ELISA for combined IgM, IgA, or IgG antibodies or only IgG antibodies specific for HIVJR-CSF gp120 protein. Each line represents data from a single mouse. (B) At 7 wpi, 3 pooled spleens from HIV+ mice and 3 control HIV− spleens were depleted of murine leukocytes prior to ELISpot assay to determine specific cellular responses to pools of 8 overlapping HIV peptides that covered the HIVJR-CSF proteome. Positive responses (denoted by an asterisk) had >50 spots/106 splenocytes and were twofold over vehicle-only (dimethylsulfoxide) controls.

Close Modal

or Create an Account

Close Modal
Close Modal